It’s not the public that needs more monitoring and oversight: it is the US regulatory agency of public health network and the pharmaceutical companies that run them.
In this paper, I provide a blueprint for a bona fide public health infrastructure based on independence of freedom from corporatism.
Since the US CDC was founded, an unholy alliance has infiltrated public health in the US —euphemistically referred to as “industry/government partnerships” and “Not-for-Profit” government entities — the wicked marriage has infused profit motives into US government agencies charged with regulating medical and pharmaceutical industries. Those involved view themselves as agents working toward a “greater good” —notwithstanding, the trappings of perverse incentives and presumed moral dictates, agencies designed by past generations to protect the US population
from harm from corporatist tendencies have been completely captured and subverted. Apologists for regulatory capture even laud the “benefits” of collusion between corporations and the agencies that have been designed — and are funded to — provide regulatory oversight (Reiss, 2011). It seems surreal to consider the brazen use and even celebration of the combination of pharmaceutical influences and matters of state. The “revolving door” between corporations and agencies has been widely recognized for some time – including the FDA.